Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

This study has been completed.
National Cancer Institute (NCI)
Chiron Corporation
Information provided by (Responsible Party):
Case Comprehensive Cancer Center Identifier:
First received: December 6, 2000
Last updated: January 8, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)